Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bristol-Myers Squibb
Age
18–60
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Chronically infected with HCV genotype 1
Treatment naive
HCV RNA viral load of ≥10\*5 IU/mL
BMI 18 to 35kg/m²
You may not be if
Women of childbearing potential (WOCBP)
Any significant acute or chronic medical illness which is not stable or is not controlled with medication and not consistent with HCV infection
HCV infected subjects who are treatment non-responder (defined as subject who received at least 12 weeks of SOC and continue to have a detectable HCV RNA level or subjects who did not attain a 2-log decline in HCV RNA levels at 12 weeks and stopped treatment
HCV infected subjects who are treatment intolerant (defined as subject who are unable to receive at least 12 weeks of SOC due to toxicities associated with interferon and/or ribavirin
HIV and/or HBV positive
Major surgery within 4 weeks of study drug administration and any gastrointestinal surgery that could impact the absorption of study drug
